Workflow
CNAS实验室认可
icon
Search documents
拱东医疗2025年业绩预减,同时发生签字会计师变更
Jing Ji Guan Cha Wang· 2026-02-14 01:11
Core Viewpoint - The company is forecasting a significant decline in net profit for 2025, alongside changes in its auditing team and the acquisition of laboratory accreditation. Group 1: Financial Performance - The company expects its net profit attributable to shareholders for 2025 to be between 44 million to 56 million yuan, representing a year-on-year decrease of 67.37% to 74.36% due to factors such as goodwill impairment, declining gross margin, and exchange rate fluctuations [2] - The final data will be confirmed in the official annual report, which has not yet been released [2] Group 2: Company Status - The company announced a change in its signing auditor for the 2025 fiscal year due to internal adjustments within the firm, with Yang Guoqing appointed as the new signing auditor, who possesses the necessary professional qualifications [3] - This change is not expected to affect the auditing process [3] Group 3: Business Development - The company received the laboratory accreditation certificate from the China National Accreditation Service for Conformity Assessment (CNAS), valid until 2032, which will enhance its testing capabilities and international recognition [4]